What is TKNO's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.47B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for TKNO?

P/E (TTM) is n/a and 52-week range is $1.91 to $9.48 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s TKNO figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for TKNO?

The company profile lists revenue (TTM) near $44M, net income (TTM) near $-1.68B, EPS (TTM) near $-0.31 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Alpha Teknova Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Hollister, California, US, 53.6M shares outstanding, ISIN US02080L1026 when available from company profile and filing metadata.

Chartloom

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Alpha Teknova, Inc. engages in the manufacture of cell culture media and supplements. The company is headquartered in Hollister, California and currently employs 158 full-time employees. The company went IPO on 2021-06-25. The firm offers three primary product types: pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. The company offers a range of standard and specialty pre-poured media plates for a variety of applications including bacteria, fungi, and nematode growth. Its two primary product categories include Lab Essentials and Clinical Solutions. Its core Lab Essentials products consist of commonly used catalog solutions and customer-specified formulations. Its Clinical Solutions products are custom products used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits.

Employees

158

Website

www.teknova.com/

IPO

2021-06-25

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)